ONCOLYTIC VIROTHERAPY : Impact Factor & More
eISSN: 2253-1572pISSN: 2253-1572
Share this on:
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
ONCOLYTIC VIROTHERAPY Journal Specifications
| Overview | |
| Publisher | DOVE MEDICAL PRESS LTD |
| Language | English |
| Frequency | Continuous publication |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2012 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in ONCOLYTIC VIROTHERAPY ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in ONCOLYTIC VIROTHERAPY
The Current State of Oncolytic Herpes Simplex Virus for Glioblastoma Treatment.
- 1 Feb 2021
- Oncolytic Virotherapy
Treatment of an Alveolar Rhabdomyosarcoma Allograft with Recombinant Myxoma Virus and Oclacitinib
- 26 May 2020
- Oncolytic Virotherapy
Virus–Receptor Interactions and Virus Neutralization: Insights for Oncolytic Virus Development
- 6 Mar 2020
- Oncolytic Virotherapy
Oncolytic Virotherapy
- 5 Mar 2020
- Oncolytic Virotherapy
Impact of Induced Syncytia Formation on the Oncolytic Potential of Myxoma Virus.
- 1 Dec 2019
- Oncolytic Virotherapy
Virus-Receptor Interactions: Structural Insights For Oncolytic Virus Development.
- 1 Oct 2019
- Oncolytic Virotherapy
The Current State of Oncolytic Herpes Simplex Virus for Glioblastoma Treatment.
- 1 Feb 2021
- Oncolytic Virotherapy
Treatment of an Alveolar Rhabdomyosarcoma Allograft with Recombinant Myxoma Virus and Oclacitinib
- 26 May 2020
- Oncolytic Virotherapy
Virus–Receptor Interactions and Virus Neutralization: Insights for Oncolytic Virus Development
- 6 Mar 2020
- Oncolytic Virotherapy
Oncolytic Virotherapy
- 5 Mar 2020
- Oncolytic Virotherapy
Impact of Induced Syncytia Formation on the Oncolytic Potential of Myxoma Virus.
- 1 Dec 2019
- Oncolytic Virotherapy
Virus-Receptor Interactions: Structural Insights For Oncolytic Virus Development.
- 1 Oct 2019
- Oncolytic Virotherapy
FAQs on ONCOLYTIC VIROTHERAPY
How long has ONCOLYTIC VIROTHERAPY been actively publishing? 
What is the publishing frequency of ONCOLYTIC VIROTHERAPY?
How many articles did ONCOLYTIC VIROTHERAPY publish last year?
What is the eISSN & pISSN for ONCOLYTIC VIROTHERAPY?
Who is the publisher of ONCOLYTIC VIROTHERAPY?
Check if your manuscript is a good match for
undefined
Upload your manuscript to get recommendations of journals
that have published papers similar to your manuscript
Drag and drop your file here
We accept manuscripts in English. File format: .doc and .docx | Maximum size: 10 MB | Word count: 200-300,000 words | File length: less than 100 pages
Do not have a manuscript right now? Use an abstract or summary
Your document is 100% secure & confidential We use 256-bit encryption for total security and
ISO/IEC 27001:2013 Certified
What all does the report include
01. Degree of Match
02. Common Topics
03. Additional
Recommendations
Recommendations